Department of Pharmacy, National Hospital Organization Kanazawa Medical Center, Kanazawa, Japan.
Anticancer Res. 2012 Mar;32(3):823-9.
Recently, it has been reported that total clearance (CLtot) of vancomycin is significantly higher in patients with malignancies compared to those without malignancies. In the present study, to clarify the mechanism of this enhancement in malignancy, we adopted rat animal models, using chemical carcinogen-induced osteosarcoma, selected lung metastatic lesions (C-SLM), transplanted into thigh muscles. The CLtot and renal clearance (CLr) of vancomycin in the tumor-bearing rats were increased compared to the ones of the control rats without tumor. However, there was no difference in the glomerular filtration rate. The plasma concentrations of interleukin (IL)-1β and IL-6, were elevated in the tumor-bearing rats. When renal proximal tubular epithelial cells (RPTEC) were exposed to IL-1β, IL-6, and tumor necrosis factor (TNF)-α simultaneously, the excretory ratio increased significantly. These findings suggest that tubular excretion or re-absorption by cytokines might be associated with changes in the vancomycin CLtot enhancement in the tumor-bearing rats.
最近有报道称,与无恶性肿瘤患者相比,恶性肿瘤患者的万古霉素总清除率(CLtot)明显更高。在本研究中,为了阐明这种增强的机制,我们采用了化学致癌物诱导的骨肉瘤大鼠动物模型,选择了肺转移病灶(C-SLM),移植到大腿肌肉中。与无肿瘤的对照组大鼠相比,荷瘤大鼠的万古霉素 CLtot 和肾清除率(CLr)增加。然而,肾小球滤过率没有差异。荷瘤大鼠的血浆白细胞介素(IL)-1β 和 IL-6 浓度升高。当肾近端管状上皮细胞(RPTEC)同时暴露于 IL-1β、IL-6 和肿瘤坏死因子(TNF)-α时,排泄率显著增加。这些发现表明,细胞因子的管状排泄或重吸收可能与荷瘤大鼠万古霉素 CLtot 增强的变化有关。